All About Value – Brexit Aside, UK Industry Sees Good Things Ahead For Healthtech Adoption
The ethos of rewarding value and new channels to promote medtech innovation are gaining ground in the UK
ABHI director of value and access Luella Trickett talks about the importance of real-world evidence in product development and value-based procurement in secondary care in the UK.
You may also be interested in...
The UK continues to build its digital health care infrastructure, as seen in the recent funding pledge for a new AI Lab. Andrew Davies is the newly appointed digital health lead at the UK’s ABHI medtech industry association. He says stakeholders first need to understand the scope of digital health care, and then adopt a networked approach, with medtech playing a full part in that evolution.
Amid a flurry of news at the ABHI, Andrew Davies, erstwhile director of market access, has been given the brief of digital lead at the UK’s main healthtech industry association. His task will be to prepare and advise UK manufacturers, as health systems transition to data-driven health care.
The “what” and the “how” involved in bringing medical technology to market for adoption by health-care systems is changing fast. The UK is laying the groundwork to be a global medtech innovation champion with two new tools: NHS England’s Long Term Plan and the newly boosted Accelerated Access Collaborative. The AAC's first chief executive, Sam Roberts, has been profiling her role in this prospective UK market access transformation.